Using ex vivo culture to assess dynamic phenotype changes in human prostate macrophages following exposure to therapeutic drugs
Clovis Boibessot(Université Laval), Paul Toren(Children's Mercy Hospital)
Cited by 10
Related Papers
Targeting the PI3K/Akt pathway in prostate cancer: Challenges and opportunities (Review)
|International Journal of Oncology|2014|158
Combined AKT and MEK Pathway Blockade in Pre-Clinical Models of Enzalutamide-Resistant Prostate Cancer
|PLoS ONE|2016|36
Pre-clinical targeting of enzalutamide-resistant prostate cancer
|cIRcle (University of British Columbia)|2017|0